Covalon Technologies
Mississauga
About Covalon Technologies
Covalon Technologies Ltd. (Covalon) is a medical device and biotechnology commercialization company. The Company is engaged in the business of developing, licensing and selling medical technologies. The Company operates in two segments: Advanced Wound Care and Specialized Medical Device Coatings. Its offices and laboratories are located in Mississauga, Ontario, Canada. Covalon sells its technologies to medical companies and distributors. Covalon’s antimicrobial technologies can be used for applications in areas, such as medical device coatings, wound care products, polymer mixes for extrusion, skin sanitizers, surface sanitizers, cosmetics, consumer products, veterinary applications, and others. Its products include ColActive, ColActive Ag, ColActive Plus, ColActive Plus Ag and CovaClear Ag. The Company’s wholly owned subsidiaries include Covalon Technologies Inc. and COV Healthcare Innovations Corp.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $6.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2019)
- Ticker: cve:COV
- Website: covalon.com
- Phone: 905-568-8400
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/covalon-technologies-67170 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.